title: Management of idiopathic pulmonary fibrosis: selected case reports.
abstract: In 2011, revised international guidelines were issued jointly by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society and the Latin American Thoracic Association, which provide a valuable framework for the diagnosis and management of idiopathic pulmonary fibrosis (IPF). However, due to the complexity of IPF, these guidelines may not comprehensively account for the management of individual IPF patients in clinical practice. We describe three patient cases that were presented and discussed during the 2013 AIR: Advancing IPF Research meeting in Nice, France. These cases highlight the heterogeneity in the presentation, history and clinical course of IPF, together with expert insights regarding the diagnosis and management of IPF in the real-life setting.
authors.affiliation: Dept of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany. Group Practice and Respiratory, Allergology and Sleep Unit, Maingau Hospital, Frankfurt, Germany. Division of Respirology, St. Michael's Hospital, Toronto, Canada kreuter@uni-heidelberg.de.
authors.forename: Michael
authors.initials: M
authors.lastname: Kreuter
authors.affiliation: Dept of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany. Group Practice and Respiratory, Allergology and Sleep Unit, Maingau Hospital, Frankfurt, Germany. Division of Respirology, St. Michael's Hospital, Toronto, Canada.
authors.forename: Peter
authors.initials: P
authors.lastname: Kardos
authors.affiliation: Dept of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany. Group Practice and Respiratory, Allergology and Sleep Unit, Maingau Hospital, Frankfurt, Germany. Division of Respirology, St. Michael's Hospital, Toronto, Canada.
authors.forename: Victor
authors.initials: V
authors.lastname: Hoffstein
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008168:Lung / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011728:Pyridones / Q000627:therapeutic use*; D020127:Recovery of Function; D012129:Respiratory Function Tests; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011728:Pyridones; C093844:pirfenidone